Data: Jastreboff et al., NEJM 2023 (Phase 2)
With Ro, Serena Williams wants to normalize the usage of GLP-1 agonists for weight loss purposes
While semaglutide overdose differs from traditional drug overdoses, taking excessive doses can cause serious complications
Target at least 100 grams of protein daily, ideally split across three to four meals
Efficacy and Safety of Orforglipron, an Oral Small-Molecule LPp-1 Receptor Agonist, on Cardiometabolic Outcomes: A Meta-Analysis and Systematic Review
Coskun T, Urva S, Roell WC et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept